Clinical Trial Update: Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating the safety and tolerability of LX101 for inherited retinal dystrophy associated with RPE65 mutations. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Retinal Dystrophy Associated with Rpe65 Mutations

Drugs mentioned

• LX101

Snippet

Sponsor: Innostellar Biotherapeutics Co.,Ltd | Conditions: Inherited Retinal Dystrophy Associated With RPE65 Mutations | Phase 1 | Status: ACTIVE_NOT_RECRUITING